Registry of Lobbyists

Registration - In-house Corporation

Eli Lilly Canada Inc. / Rhonda Pacheco, President and General Manager

Registration Information

In-house Corporation name: Eli Lilly Canada Inc.
Responsible Officer Name: Rhonda Pacheco, President and General Manager 
Responsible Officer Change History
Initial registration start date: 2005-12-19
Registration status: Active
Registration Number: 945684-6034

Associated Communications

Total Number of Communication Reports: 121

Monthly communication reports in the last 6 months: 6

Version 1 of 30 (2005-12-19 to 2007-04-05)

Version 1 of 30 (2005-12-19 to 2007-04-05) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Eli Lilly Canada Inc.
3650 Danforth Avenue
Toronto, ON  M1N 2E8
Telephone number: 416-699-7309
Fax number: 416-694-0487  
Responsible officer name and position during the period of this registration: David Ricks, President and General Manager  
Description of activities: Pharmaceutical manufacturer, research and development, commercial operations.
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Canada K1P 5G4

Elanco Animal Health
150 Research Park Lane, Suite 120
Guelph, ON
Canada N1G 4T2

Rx & D, Canada's Research-Based Pharmaceutical Companies
55 Metcalfe Street, Suite 1220
Ottawa, ON
Canada K1P 6L5

Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No

B. Lobbyists Employed by the Corporation

Name: D.Terrence McCool
Position title: Vice President, Corporate Affairs
Public offices held: No

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Canadian International Development Agency (CIDA), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
Subject Matter: Retrospective: General information sharing with Health Canada, Industry Canada on Health policy issues and Intellectual property including Data protection
Subject Matter: Prospective: Intellectual Property Data protection and changes to Patented Medecine Notice of compliance (PMNOC) linkage regulationsHealth Canada - National Pharmaceutical strategy Patented Medecine Prices Review Board (PMPRB), Food & Drug Act changes

Details Regarding the Identified Subject Matter

Categories Description
Legislative Proposal Intellectual Property - Data protection and changes to Patented Medecine (Notice of compliance) (PMNOC) regulations
Regulation Patented Medecine Notice of compliance (PMNOC) Regulations

Date Modified: